4/A//SEC Filing
Anthera Pharmaceuticals Inc 4/A
Accession 0001214659-17-001675
CIK 0001316175operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:48 PM ET
Size
5.7 KB
Accession
0001214659-17-001675
Insider Transaction Report
Form 4/AAmended
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2016-12-06+200,000→ 200,000 totalExercise: $1.47Exp: 2026-12-06→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This is an amendment to correct an error in the original form 4 filed on December 6, 2016. The Option vests four years as follows: 25% of the stock options shall vest one year following the vesting commencement date, with the remaining 75% of the stock options vesting in 36 equal monthly installments thereafter. The vesting commencement date is December 6, 2016. The option will expire on December 6, 2026.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:48 PM ET
- Size
- 5.7 KB